Suppr超能文献

[使用[Sar1,Ile8]血管紧张素II进行动脉内灌注化疗治疗膀胱癌]

[Intra-arterial infusion chemotherapy with [Sar1, Ile8] angiotensin II in bladder cancer].

作者信息

Morita T, Kikuchi T, Hara Y, Ishikawa S, Kobayashi Y, Ishiyama S, Tozuka K, Goto K, Nakashima N, Takahashi K

机构信息

Dept. of Urology, Jichi Medical School, Tochigi, Japan.

出版信息

Gan To Kagaku Ryoho. 1989 Oct;16(10):3417-22.

PMID:2802636
Abstract

Twenty patients with bladder cancer were treated with intra-arterial infusion chemotherapy using CDDP and ADM in combination with [Sar1, Ile8] angiotensin II. A catheter was introduced into internal iliac artery by Seldinger's technique, and 100 mg of CDDP, 50 mg of ADM and 1 mg of [Sar1, Ile8] angiotensin II were infused through the catheter for 40 minutes. CR was observed in 8 of 20 patients. PR in 11 and NC in 1. Therefore, the response rate (CR + PR) was 95% (19/20). Side effects were generally mild and consisted of leukopenia, nausea, vomiting, diarrhea, alopecia, skin pigmentation and headache. Catheter-related complications were not observed. This study demonstrated that intra-arterial infusion chemotherapy with CDDP and ADM in combination with [Sar1, Ile8] angiotensin II was extremely effective in treating patients with bladder cancer.

摘要

20例膀胱癌患者接受了顺铂(CDDP)、阿霉素(ADM)联合[Sar1,Ile8]血管紧张素II的动脉内灌注化疗。采用Seldinger技术将导管插入髂内动脉,通过导管注入100mg顺铂、50mg阿霉素和1mg[Sar1,Ile8]血管紧张素II,持续40分钟。20例患者中8例观察到完全缓解(CR),11例部分缓解(PR),1例无变化(NC)。因此,缓解率(CR+PR)为95%(19/20)。副作用一般较轻,包括白细胞减少、恶心、呕吐、腹泻、脱发、皮肤色素沉着和头痛。未观察到与导管相关的并发症。本研究表明,顺铂和阿霉素联合[Sar1,Ile8]血管紧张素II的动脉内灌注化疗在治疗膀胱癌患者方面极其有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验